Chris Degnan
CIK 1741968 · Chief Financial Officer · last filed 2026-02-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$85.0K
Companies
3
Total Filings
11
Lifetime Open-Market Net
$27.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| URGN | Chief Financial Officer | 2,280 | $29.72 | $67.8K | -$37.1K | 3 | 2026-02-03 |
| Galera Therapeutics, Inc. (GRTX) Delisted | Chief Financial Officer | 10,000 | $0.14 | $1.4K | $19.6K | 6 | 2023-03-14 |
| VRCA | Chief Financial Officer | 3,000 | $5.73 | $17.2K | $45.0K | 2 | 2019-03-04 |
Recent Filings · Page 2 of 2
11 filingsForm 4 transactions across all companies, newest first.
Showing 11–11 of 11
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.